MedTrace Logo

Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients

NCT01003483 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-04-01

No results posted yet for this study

Summary

The purpose of this study is to compare the influence of Orlistat and Metformin on obesity treatment in obese PCOS women.

Conditions

Interventions

DRUG

orlistat

Tablet,120mg,three times a day,three months

Sponsors & Collaborators

  • Yazd Medical University

    collaborator OTHER

  • Yazd Research & Clinical Center for Infertility

    lead OTHER

Principal Investigators

  • Abbas Aflatoonian, Professor · Research and Clinical center for Infertility

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-12-01
Primary Completion
2009-08-31
Completion
2009-11-30

Countries

  • Iran

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01003483 on ClinicalTrials.gov